Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Ivermectin  COVID-19 treatment studies for Ivermectin  C19 studies: Ivermectin  Ivermectin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Joint Statement of the FLCCC Alliance and British Ivermectin Recommendation Development Group on Retraction of Early Research on Ivermectin
FLCCC Alliance and British Ivermectin Recommendation Development Group (News)
FLCCC, Joint Statement of the FLCCC Alliance and British Ivermectin Recommendation Development Group on Retraction of.., Alliance and British Ivermectin Recommendation Development Group (News)
Jul 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
News release noting that ivermectin remains effective after excluding Elgazzar et al. Given the large magnitude effects and 61 studies, excluding one study with ~3% of patients does not significantly change the evidence base.
FLCCC et al., 16 Jul 2021, preprint, 2 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperIvermectinAll
Abstract: FOR IMMEDIATE RELEASE July 16, 2021 CONTACT: Press@FLCCC.net rob@themarketingdepartment.co.uk Joint Statement of the FLCCC Alliance and British Ivermectin Recommendation Development Group on Retraction of Early Research on Ivermectin A reexamination of the data without the earlier research continues to prove that ivermectin is effective in preventing and treating COVID-19 WASHINGTON, D.C. and BATH, SOMERSET, U.K. – The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, and the British Ivermectin Recommendation Development Group (BIRD), a U.K. based group of medical and scientific experts from over 15 countries, are concerned over the misrepresentation of science in the recent article published in the Guardian regarding the withdrawal of Professor Emeritus Ahmed Elgazzar!s study into ivermectin that was first posted December 16, 2020. Contrary to the voices quoted in the article, there is no scientific basis to state that the removal of one study from meta-analyses would "reverse results.!#Worryingly, this article!s insinuation is reported as if it is fact. According to the most recent analyses by BIRD, excluding the Elgazzar data from the cited metaanalyses by Bryant and Hill does not change the conclusions of these reviews, with the findings still clearly favouring ivermectin for both prevention and treatment. This article raise questions of journalistic integrity and we invite the Guardian to make appropriate corrections to the reporting and properly check the veracity of their claims. $This is not just about correcting facts but about people!s lives,” said Dr. Tess Lawrie, director of the Evidence-Based Medicine Consultancy and organizer of the BIRD group. $Ivermectin is already in use around the world and can reach the poorest people long before other expensive COVID treatments will ever get to them. Ivermectin has an ever-increasing evidence base that shows that it works –even the prestigious Institute Pasteur in France has confirmed that the evidence is sound.” $When we examine the extensive evidence on ivermectin as a treatment for COVID-19 without this latest study, we still see a significant reduction in the spread of COVID-19 as well as a reduction in hospitalizations and death,” said Dr. Pierre Kory, president and chief medical officer of the FLCCC. $All science needs to be scrutinized. As some of the most published researchers in our fields, we are used to having our work examined by others. I hope that Dr. Elgazzar!s work will be impartially judged and any errors that might be found are corrected.” About the Front Line COVID-19 Critical Care Alliance The FLCCC Alliance was organized in March 2020 by a group of highly published, world renowned Critical Care physician/scholars – with the academic support of allied physicians from around the world – to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness. Their MATH+ Hospital Treatment Protocol, introduced in March 2020, has saved thousands of patients who were critically ill with COVID-19. Now, the FLCCC!s new I-Mask+ Prophylaxis and Early At-Home Outpatient Treatment Protocol with Ivermectin has been released – and is a potential solution to the global pandemic. For more information: www.FLCCC.net About the BIRD group Convened by The Evidenced-Based Medical Consultancy (E-BMC) in Bath, United Kingdom, the BIRD meeting was assembled..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit